Physician profile
David Allen Beeks
NPI 1013948058
$7,157.65
in general payments reported to CMS, 2019-2025
20 companies · $552 in 2025
The $552 reported for 2025 was less than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $750 · 2020: $1,391 · 2021: $161 · 2022: $926 · 2023: $2,308 · 2024: $1,071 · 2025: $552.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,677 · Travel and Lodging: $1,254.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,677.37 |
| Travel and Lodging | $1,253.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,990.53 | 2022-2025 | Osteocool Rf Ablation System, Kyphon Express II Kyphopak Tray, Navlock |
| Si-Bone, INC. | $1,213.90 | 2019-2020 | |
| Medtronic USA, INC. | $629.26 | 2019-2020 | |
| Stryker Corporation | $371.25 | 2019-2024 | Spinejack, Gamma |
| Integra Lifesciences Corporation | $177.57 | 2021-2022 | |
| Intrinsic Therapeutics | $129.49 | 2025 | Barricaid Acd (Annular Closure Device) |
| Depuy Synthes Sales INC. | $93.70 | 2020-2023 | Orthovisc, Monovisc, Teligen |
| Providence Medical Technology, INC. | $90.98 | 2025 | |
| Abbott Laboratories | $90.27 | 2022-2023 | Proclaim |
| Spineology INC. | $72.48 | 2019-2022 | |
| Orthofix Medical, INC. | $53.20 | 2019-2024 | Spinal-Stim |
| Innovation Technologies INC | $51.00 | 2019 | |
| Kci USA, INC. | $47.06 | 2019 | |
| Kerecis Limited | $46.66 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Zimmer Biomet Holdings, INC. | $33.78 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $16.73 | 2024 | Durolane |
| Sanara Medtech INC. | $13.49 | 2024 | Celleraterx |
| Convatec INC. | $12.57 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $12.25 | 2019 | |
| Wright Medical Technology, INC. | $11.48 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Beeks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.